The total return over the past 12 months is -64.98% vs. +16.94% for the S&P 500. So far it's up -46.52% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (64.97%) | (7.68%) | (31.63%) | (39.57%) | (41.47%) | (40.49%) |
| Total Return CAGR | (64.98%) | (7.70%) | (31.63%) | (39.57%) | (41.47%) | (40.49%) |
| Revenue CAGR | N/A | N/A | N/A | +11.34% | (8.93%) | +2.88% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Microbot Medical Inc. (MBOT)
| Year | Start price | End price | MBOT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.00 | $1.07 | (46.52%) | +14.51% | (61.03%) |
| 2025 | $1.12 | $2.00 | +78.56% | +17.72% | +60.84% |
| 2024 | $1.64 | $1.12 | (31.70%) | +24.89% | (56.59%) |
| 2023 | $3.01 | $1.64 | (45.51%) | +26.19% | (71.70%) |
| 2022 | $7.50 | $3.01 | (59.86%) | (18.17%) | (41.69%) |
| 2021 | $6.89 | $7.50 | +8.85% | +28.74% | (19.89%) |
| 2020 | $10.17 | $6.89 | (32.26%) | +18.37% | (50.63%) |
| 2019 | $1.72 | $10.17 | +491.54% | +31.22% | +460.32% |
| 2018 | $15.30 | $1.72 | (88.76%) | (4.56%) | (84.20%) |
| 2017 | $91.50 | $15.30 | (83.28%) | +21.70% | (104.98%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
